Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,102.44 -712.12 (-1.83%) Hang Seng
17,942.64 +0.86 (+0.00%) FTSE 100
8,172.40 +25.54 (+0.31%) Bitcoin USD
66,323.45 +57.76 (+0.09%) CMC Crypto 200
1,411.38 +23.22 (+1.67%)
OZK Nov 2024 40.000 call
| Previous close | 2.3500 |
| Open | 2.3500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 40.00 |
| Expiry date | 2024-11-15 |
| Day's range | 2.3500 - 2.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksBank OZK (OZK) Ratings Affirmed by Moody's Amid CRE Concerns
Bank OZK's (OZK) ratings and outlook are affirmed by Moody's. This indicates solid financial metrics, while concerns remain in the form of substantial CRE concentration.
ZacksBank OZK (OZK) Rides on High Rates, Fee Income Amid Cost Woes
Bank OZK (OZK) is well-poised for growth given high rates, its restructuring efforts and a solid balance sheet position. However, a rising expense base and deteriorating asset quality are concerns.
- Reuters
Regional lender Bank OZK plunges as Citi turns bearish over loan concerns
The commercial real estate (CRE) sector, which has been roiled by higher borrowing costs and lower occupancy, has become a key cause of concern for investors and lenders. Citi said the San Diego property "has been rejected numerous times by sizable pharmaceutical companies" and has no known leases. The two projects together account for 3.8% of Bank OZK's non-purchased loans and are more than 8.1 times larger than its allowance for credit losses for construction loans, Citi said.
